Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer.
Biomed Mater. 2024 Mar 6;19(3). doi: 10.1088/1748-605X/ad2c1c.
Biomed Mater. 2024.
PMID: 38387062
Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug.
Ugalde-Arbizu M, Aguilera-Correa JJ, García-Almodóvar V, Ovejero-Paredes K, Díaz-García D, Esteban J, Páez PL, Prashar S, San Sebastian E, Filice M, Gómez-Ruiz S.
Ugalde-Arbizu M, et al. Among authors: garcia almodovar v.
Pharmaceutics. 2023 Feb 7;15(2):560. doi: 10.3390/pharmaceutics15020560.
Pharmaceutics. 2023.
PMID: 36839883
Free PMC article.
Item in Clipboard
Multifunctional Silica-Based Nanoparticles with Controlled Release of Organotin Metallodrug for Targeted Theranosis of Breast Cancer.
Ovejero Paredes K, Díaz-García D, García-Almodóvar V, Lozano Chamizo L, Marciello M, Díaz-Sánchez M, Prashar S, Gómez-Ruiz S, Filice M.
Ovejero Paredes K, et al. Among authors: garcia almodovar v.
Cancers (Basel). 2020 Jan 12;12(1):187. doi: 10.3390/cancers12010187.
Cancers (Basel). 2020.
PMID: 31940937
Free PMC article.
Item in Clipboard
Cite
Cite